Evolution of cellular immunotherapy: from allogeneic transplant to dendritic cell vaccination as treatment for multiple myeloma.
about
CUZD1 and anti-CUZD1 antibodies as markers of cancer and inflammatory bowel diseasesTrans-nodal migration of resident dendritic cells into medullary interfollicular regions initiates immunity to influenza vaccine.The tumor protection effect of high-frequency administration of whole tumor cell vaccine and enhanced efficacy by the protein component from Agrocybe aegerita.Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back.Dynamic analysis of immune and cancer cell interactions at single cell level in microfluidic droplets.Promising therapies in multiple myeloma.
P2860
Evolution of cellular immunotherapy: from allogeneic transplant to dendritic cell vaccination as treatment for multiple myeloma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Evolution of cellular immunoth ...... reatment for multiple myeloma.
@en
type
label
Evolution of cellular immunoth ...... reatment for multiple myeloma.
@en
prefLabel
Evolution of cellular immunoth ...... reatment for multiple myeloma.
@en
P2860
P356
P1433
P1476
Evolution of cellular immunoth ...... reatment for multiple myeloma.
@en
P2093
David Avigan
Jon Arnason
P2860
P304
P356
10.2217/IMT.12.118
P577
2012-10-01T00:00:00Z